Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer

Fig. 2

High expression of B3GALT5 in breast cancer tissue correlates with poor clinical outcome. Relapse-free survival (RFS) and overall survival (OS) comparing the 202 breast cancer patients with high (black) and low (gray) expression of B3GALT5 in tumor and adjacent non-tumor parts was analyzed. a–d Kaplan–Meier plots of RFS (a, c) and OS (b, d) for patients with breast cancer in relation to the expression levels of B3GALT5 in tumor parts (a, b) and adjacent non-tumor parts (c, d) of the cancer tissues. e, f Kaplan–Meier plots of RFS (e) and OS (f) for patients with stages I–II and luminal A and B breast cancer in relation to the expression levels of B3GALT5 in adjacent non-tumor parts of the cancer tissues. P values were calculated by log-rank test

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us